Original
El papel pronóstico del SUVmáx basal y cambio del SUVmáx en la PET/TC con18F-FDG en pacientes con cáncer de mama con ganglios positivos que reciben quimioterapia neoadyuvante
The prognostic role of baseline 18F-FDG PET/CT SUVmax and SUVmax change in patients with node-positive breast cancer receiving neoadjuvant chemotherapy
C. Cana, N. Akdenizb, H. Kömeka,
, C. Gündoğana, Z. Urakçıc, A. Işıkdoğanc
Autor para correspondencia
a Department of Nuclear Medicine, Saglik Bilimleri University Diyarbakir Gazi Yasargil Training and Research Hospital, Diyarbakir, Turquía
b Department of Medical Oncology, Adiyaman Training and Research Hospital, Adiyaman, Turquía
c Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turquía
Leído
209
Vecesse ha leído el artículo
56
Total PDF
153
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 2 | 0 | 2 |
| 2025 5 | 1 | 2 | 3 |
| 2024 5 | 1 | 2 | 3 |
| 2023 12 | 3 | 2 | 5 |
| 2023 9 | 4 | 1 | 5 |
| 2023 6 | 2 | 0 | 2 |
| 2023 3 | 3 | 0 | 3 |
| 2022 10 | 8 | 2 | 10 |
| 2022 9 | 1 | 0 | 1 |
| 2022 8 | 12 | 4 | 16 |
| 2022 7 | 3 | 2 | 5 |
| 2022 6 | 1 | 2 | 3 |
| 2022 5 | 3 | 2 | 5 |
| 2022 4 | 2 | 2 | 4 |
| 2022 3 | 4 | 6 | 10 |
| 2022 2 | 14 | 8 | 22 |
| 2021 1 | 89 | 15 | 104 |
| 2021 11 | 0 | 4 | 4 |
| 2021 10 | 0 | 2 | 2 |
Mostrar todo
